Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
entecavir (baraclude) (5 trials)
fuzhenghuayu (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
thymalfasin (zadaxin) (2 trials)
Fibrosis (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Liver Cirrhosis (Phase 4)
Trials (5 total)
Trial APIs (4 total)